The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 25, 2025
Filed:
May. 13, 2022
Applicant:
Emory University, Atlanta, GA (US);
Inventors:
Assignee:
Emory University, Atlanta, GA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/28 (2006.01); A61K 31/282 (2006.01); A61K 33/243 (2019.01); A61P 35/00 (2006.01); B32B 21/02 (2006.01); C07C 229/00 (2006.01); C09D 5/02 (2006.01); C09D 5/08 (2006.01); C09D 7/65 (2018.01);
U.S. Cl.
CPC ...
A61K 31/28 (2013.01); A61K 31/282 (2013.01); A61K 33/243 (2019.01); A61P 35/00 (2018.01); B32B 21/02 (2013.01); C07C 229/00 (2013.01); C09D 5/02 (2013.01); C09D 5/08 (2013.01); C09D 7/65 (2018.01);
Abstract
The disclosure relates polyoxometalate complexes and uses in the management, treatment, or prevention of cancer. In certain embodiments, the polyoxometalate complexes comprise polydentate oxygen bridging ligands such as those of the following formula: [POM{(OCH)CX}], [MO{(OCH)CX}], [VO{(OCH)CX}], salts, or derivatives thereof wherein POM is a polyoxometalate, M is a metal, and X is defined herein. In certain embodiments, the disclosure relates to pharmaceutical compositions comprising polyoxometalate complexes disclosed herein.